SCHEMBL17427072

SCHEMBL17427072

Cc1cc(-c2cccc3ccccc23)cc(-c2nc(Cl)cc(-c3cccc4ccccc34)n2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
KMT2A Q03164 2/20 0.43
ENPP3 O14638 1/20 0.41
ENPP1 P22413 1/20 0.41
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
MAPT P10636 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.38
KDM4E B2RXH2 3/20 0.37
CRHR1 P34998 3/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP3A4 P08684 1/20 0.37
HTR2C P28335 2/20 0.36
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16805025 0.89 ENPP3 (0.49) LMNAKMT2AENPP3ENPP1MEN1
SCHEMBL17427082 0.84 ADORA2A (0.46) LMNAKMT2AENPP3ENPP1MAPT
SCHEMBL17427079 0.84 ENPP3 (0.41) LMNAKMT2AENPP3ENPP1MAPT
SCHEMBL17412408 0.81 HSP90AA1 (0.49) KMT2AHSP90AA1HSP90AB1MAPTL3MBTL1
SCHEMBL24212279 0.81 LMNA (0.46) LMNAKMT2AENPP3ENPP1HSP90AA1
SCHEMBL25774989 0.80 ENPP3 (0.50) LMNAKMT2AENPP3ENPP1MAPT
SCHEMBL21701674 0.80 LMNA (0.51) LMNAKMT2AHSP90AA1HSP90AB1MAPT
SCHEMBL17412428 0.76 PIM1 (0.46) LMNAKMT2AENPP3ENPP1HSP90AA1
SCHEMBL16805049 0.76 PIM1 (0.46) LMNAKMT2AENPP3ENPP1MAPT
SCHEMBL16805037 0.76 PIM1 (0.52) ENPP3ENPP1MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9847492-B2 Organic compound and organic light emitting diode device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-12-19 US disclosed
US-9847492-B2 Organic compound and organic light emitting diode device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-12-19 US disclosed
US-20160013420-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-01-14 US disclosed
US-20160013420-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160013420-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE INCLUDING THE SAME OXER1, AOX1, CYP1A1 LMNA 2971/4885KMT2A 1254/4885ENPP3 4017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.